![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
EU WC
Listed Suppliers
0
USA (Orange Book)
Europe
Canada
Australia
0
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
0
https://www.prnewswire.com/news-releases/ani-pharmaceuticals-announces-launch-of-aspirin-and-extended-release-dipyridamole-capsules-25mg200mg-300929488.html
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-august-21-2019-1566366765.pdf
https://www.prnewswire.com/news-releases/lannett-launches-aspirin-and-extended-release-dipyridamole-capsules-300869795.html
https://www.thehindubusinessline.com/companies/glenmark-pharma-gets-usfda-nod-for-antiplatelet-drug/article27259993.ece
https://www.prnewswire.com/news-releases/lannett-receives-fda-approval-for-aspirin-and-extended-release-dipyridamole-capsules-25-mg200-mg-300819106.html
https://www.biospectrumasia.com/news/33/12377/dr-reddys-launches-aspirin-and-extended-release-dipyridamole-capsules-in-usa.html
https://www.thepharmaletter.com/in-brief/brief-ftc-imposes-conditions-on-amneal-acquisition-of-impax
https://www.ftc.gov/news-events/press-releases/2018/07/ftc-approves-final-order-imposing-conditions-merger-generic-drug
https://www.prnewswire.com/news-releases/ani-pharmaceuticals-completes-acquisition-of-generic-products-and-assets-from-amnealimpax-300642867.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206753
http://www.reuters.com/article/usa-court-ftc-boehringer-idUSL2N14Y2Z7
http://www.fiercepharmaasia.com/story/idt-australia-release-fda-nod-23-generics-begs-question-wheres-beef/2015-04-14